ESR1 and triple-negative breast carcinoma: Metformin, which activates AMPK, was shown to inhibit cell proliferation and induce apoptosis in the triple-negative breast cancer cell line, as well as the estrogen receptor (ER) α-positive and the human epidermal receptor (HER) 2-positive cell lines.